Figure 1.
Figure 1. In vivo treatment of ABC-DLBCL SU-DHL-2 xenografts with MK-8228 as single agent and in combination with other targeted drugs.

In vivo treatment of ABC-DLBCL SU-DHL-2 xenografts with MK-8228 as single agent and in combination with other targeted drugs.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal